Brand Acumen, a leader in pharmaceutical brand naming, has unveiled its latest creation: SYMBRAVO®, the new name for Axsome Therapeutics’ novel migraine treatment.
Share this post
SYMBRAVO: A Bold New Name for a Breakthrough…
Share this post
Brand Acumen, a leader in pharmaceutical brand naming, has unveiled its latest creation: SYMBRAVO®, the new name for Axsome Therapeutics’ novel migraine treatment.